Cargando…
Microglial Activation and Priming in Alzheimer’s Disease: State of the Art and Future Perspectives
Alzheimer’s Disease (AD) is the most common cause of dementia, having a remarkable social and healthcare burden worldwide. Amyloid β (Aβ) and protein Tau aggregates are disease hallmarks and key players in AD pathogenesis. However, it has been hypothesized that microglia can contribute to AD pathoph...
Autores principales: | Bivona, Giulia, Iemmolo, Matilda, Agnello, Luisa, Lo Sasso, Bruna, Gambino, Caterina Maria, Giglio, Rosaria Vincenza, Scazzone, Concetta, Ghersi, Giulio, Ciaccio, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820926/ https://www.ncbi.nlm.nih.gov/pubmed/36614325 http://dx.doi.org/10.3390/ijms24010884 |
Ejemplares similares
-
The Role of Vitamin D as a Biomarker in Alzheimer’s Disease
por: Bivona, Giulia, et al.
Publicado: (2021) -
Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases
por: Bivona, Giulia, et al.
Publicado: (2022) -
COVID-19 and Alzheimer’s Disease
por: Ciaccio, Marcello, et al.
Publicado: (2021) -
Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine
por: Lo Sasso, Bruna, et al.
Publicado: (2021) -
The Value of a Complete Blood Count (CBC) for Sepsis Diagnosis and Prognosis
por: Agnello, Luisa, et al.
Publicado: (2021)